Follow
Jonathan Constance
Jonathan Constance
Verified email at utah.edu
Title
Cited by
Cited by
Year
Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications
C Stockmann, JE Constance, JK Roberts, J Olson, EH Doby, K Ampofo, ...
Clinical pharmacokinetics 53 (5), 429-454, 2014
452014
Herbal medicines: challenges in the modern world. Part 4. Canada and United States
KM Job, TKL Kiang, JE Constance, CMT Sherwin, EY Enioutina
Expert review of clinical pharmacology 9 (12), 1597-1609, 2016
432016
Targeting malignant mitochondria with therapeutic peptides
JE Constance, CS Lim
Therapeutic delivery 3 (8), 961-979, 2012
432012
Considerations in the pharmacologic treatment and prevention of neonatal sepsis
C Stockmann, MG Spigarelli, SC Campbell, JE Constance, JD Courter, ...
Pediatric Drugs 16 (1), 67-81, 2014
412014
Direct induction of apoptosis using an optimal mitochondrially targeted p53
M Mossalam, KJ Matissek, A Okal, JE Constance, CS Lim
Molecular pharmaceutics 9 (5), 1449-1458, 2012
412012
Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants
JK Roberts, C Stockmann, JE Constance, J Stiers, MG Spigarelli, ...
Clinical pharmacokinetics 53 (7), 581-610, 2014
372014
Xenobiotic metabolism of plant secondary compounds in juniper (Juniperus monosperma) by specialist and generalist woodrat herbivores, genus Neotoma
SL Haley, JG Lamb, MR Franklin, JE Constance, MD Dearing
Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology …, 2007
372007
Controlling subcellular localization to alter function: Sending oncogenic Bcr–Abl to the nucleus causes apoptosis
AS Dixon, M Kakar, KMH Schneider, JE Constance, BC Paullin, CS Lim
Journal of controlled release 140 (3), 245-249, 2009
362009
A propensity-matched cohort study of vancomycin-associated nephrotoxicity in neonates
JE Constance, AH Balch, C Stockmann, MW Linakis, EK Korgenski, ...
Archives of Disease in Childhood-Fetal and Neonatal Edition 101 (3), F236-F243, 2016
332016
Special population considerations and regulatory affairs for clinical research
KN Grimsrud, CMT Sherwin, JE Constance, C Tak, AF Zuppa, ...
Clinical research and regulatory affairs 32 (2), 45-54, 2015
332015
Improved coiled-coil design enhances interaction with Bcr-Abl and induces apoptosis
AS Dixon, GD Miller, BJ Bruno, JE Constance, DW Woessner, TP Fidler, ...
Molecular pharmaceutics 9 (1), 187-195, 2012
302012
Xenobiotic metabolism of plant secondary compounds in oak (Quercus agrifolia) by specialist and generalist woodrat herbivores, genus Neotoma
SL Haley, JG Lamb, MR Franklin, JE Constance, MD Dearing
Journal of Chemical Ecology 33 (11), 2111-2122, 2007
272007
Pediatric vancomycin dosing: trends over time and the impact of therapeutic drug monitoring
AH Balch, JE Constance, EA Thorell, C Stockmann, EK Korgenski, ...
The Journal of Clinical Pharmacology 55 (2), 212-220, 2015
252015
“Pharm-ecology” of diet shifting: biotransformation of plant secondary compounds in creosote (Larrea tridentata) by a woodrat herbivore, Neotoma lepida
SL Haley, JG Lamb, MR Franklin, JE Constance, MD Dearing
Physiological and Biochemical Zoology 81 (5), 584-593, 2008
232008
Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections
KM Job, J Olson, C Stockmann, JE Constance, EY Enioutina, JE Rower, ...
Expert review of anti-infective therapy 14 (8), 731-746, 2016
202016
Changing the subcellular location of the oncoprotein Bcr-Abl using rationally designed capture motifs
AS Dixon, JE Constance, T Tanaka, TH Rabbitts, CS Lim
Pharmaceutical research 29 (4), 1098-1109, 2012
192012
Characteristics and publication patterns of obstetric studies registered in ClinicalTrials. gov
C Stockmann, CMT Sherwin, G Koren, SC Campbell, JE Constance, ...
The Journal of Clinical Pharmacology 54 (4), 432-437, 2014
172014
Selective targeting of c-Abl via a cryptic mitochondrial targeting signal activated by cellular redox status in leukemic and breast cancer cells
JE Constance, SD Despres, A Nishida, CS Lim
Pharmaceutical research 29 (8), 2317-2328, 2012
172012
Enhanced and selective killing of chronic myelogenous leukemia cells with an engineered BCR-ABL binding protein and imatinib
JE Constance, DW Woessner, KJ Matissek, M Mossalam, CS Lim
Molecular pharmaceutics 9 (11), 3318-3329, 2012
162012
A once‐per‐day, drug‐in‐food protocol for prolonged administration of antiepileptic drugs in animal models
A Ali, Y Dua, JE Constance, MR Franklin, FE Dudek
Epilepsia 53 (1), 199-206, 2012
162012
The system can't perform the operation now. Try again later.
Articles 1–20